Inert lymphomas do not go away on their own.
Clinically indolent lymphomas are those that progress slowly, such as follicular lymphomas, small lymphocytic lymphomas, and marginal zone lymphomas. The slower progression of inert lymphomas results in a longer survival period compared to more aggressive lymphomas (e.g., diffuse large B-cell lymphoma).
However, inert lymphoma is a type of hematologic malignancy and is unlikely to go away on its own. Some patients may not be treated at the early stage of the disease, but they need to undergo regular review and assessment of the progress of the disease, and they still need to be actively treated once progressive enlargement of the spleen, severe anemia, thrombocytopenia and other manifestations occur.
It is recommended that patients with inert lymphoma should go to the Department of Hematology for timely consultation, complete relevant examinations to evaluate their condition, and have their physicians formulate individualized treatment plans for treatment.